The Board of Directors of Santen Pharmaceutical Co., Ltd. has authorized a buyback plan on May 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,639 JPY | -0.27% | +1.24% | +16.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.65% | 3.78B | |
+42.26% | 748B | |
+33.79% | 598B | |
-5.61% | 356B | |
+18.35% | 325B | |
+4.95% | 283B | |
+17.60% | 245B | |
+9.25% | 211B | |
-4.17% | 209B | |
+3.07% | 166B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Santen Pharmaceutical Co., Ltd. authorizes a Buyback Plan.